JP6933983B2 - 衛生化飲料水と共に使用するためのビタミンeを含有するイソオキサゾリン溶液 - Google Patents

衛生化飲料水と共に使用するためのビタミンeを含有するイソオキサゾリン溶液 Download PDF

Info

Publication number
JP6933983B2
JP6933983B2 JP2017566402A JP2017566402A JP6933983B2 JP 6933983 B2 JP6933983 B2 JP 6933983B2 JP 2017566402 A JP2017566402 A JP 2017566402A JP 2017566402 A JP2017566402 A JP 2017566402A JP 6933983 B2 JP6933983 B2 JP 6933983B2
Authority
JP
Japan
Prior art keywords
drinking water
pharmaceutical composition
present
medicated
isooxazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017566402A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018521995A (ja
JP2018521995A5 (enExample
Inventor
フロッシュレー−シグニョー,アニー
リーヒ,アンヌ
Original Assignee
インターベット インターナショナル ベー. フェー.
インターベット インターナショナル ベー. フェー.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インターベット インターナショナル ベー. フェー., インターベット インターナショナル ベー. フェー. filed Critical インターベット インターナショナル ベー. フェー.
Publication of JP2018521995A publication Critical patent/JP2018521995A/ja
Publication of JP2018521995A5 publication Critical patent/JP2018521995A5/ja
Application granted granted Critical
Publication of JP6933983B2 publication Critical patent/JP6933983B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Fodder In General (AREA)
  • Mechanical Engineering (AREA)
  • Ceramic Engineering (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
JP2017566402A 2015-06-23 2016-06-22 衛生化飲料水と共に使用するためのビタミンeを含有するイソオキサゾリン溶液 Active JP6933983B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15173454.8 2015-06-23
EP15173454 2015-06-23
PCT/EP2016/064449 WO2016207234A1 (en) 2015-06-23 2016-06-22 Isoxazoline solution containing vitamin e for use with sanitized drinking water

Publications (3)

Publication Number Publication Date
JP2018521995A JP2018521995A (ja) 2018-08-09
JP2018521995A5 JP2018521995A5 (enExample) 2019-07-25
JP6933983B2 true JP6933983B2 (ja) 2021-09-08

Family

ID=53488226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017566402A Active JP6933983B2 (ja) 2015-06-23 2016-06-22 衛生化飲料水と共に使用するためのビタミンeを含有するイソオキサゾリン溶液

Country Status (10)

Country Link
US (3) US20180169073A1 (enExample)
EP (1) EP3313400B1 (enExample)
JP (1) JP6933983B2 (enExample)
CN (1) CN107750159B (enExample)
BR (1) BR112017027855B1 (enExample)
ES (1) ES2920394T3 (enExample)
HU (1) HUE059228T2 (enExample)
MX (1) MX383746B (enExample)
PL (1) PL3313400T3 (enExample)
WO (1) WO2016207234A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
KR102668200B1 (ko) * 2015-10-28 2024-05-23 주식회사유한양행 지속형 fgf21 융합 단백질 및 이를 포함하는 약학적 조성물
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
AU2018385766B2 (en) 2017-12-15 2022-12-01 Tarsus Pharmaceuticals, Inc. Isoxazoline parasiticide formulations and methods for treating blepharitis
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
BR112022012269A2 (pt) 2019-12-18 2022-08-30 Elanco Tiergesundheit Ag Derivados de isoxazolina como pesticidas
CN116194450A (zh) 2020-07-24 2023-05-30 礼蓝美国公司 用于制备异噁唑啉化合物及其中间体的工艺
CA3211576A1 (en) * 2021-03-11 2022-09-15 In The Bowl Animal Health, Inc. Oral canine feed and methods for controlling tick infestations in a canine
CN114306231B (zh) * 2021-12-29 2023-03-24 天津市中升挑战生物科技有限公司 一种氟雷拉纳杀虫剂及其制备方法和应用
CN115266988A (zh) * 2022-08-01 2022-11-01 江苏慧聚药业股份有限公司 一种氟雷拉钠有关物质的检测方法
CN117064851A (zh) * 2023-09-20 2023-11-17 中国农业大学 一种异噁唑啉类驱虫药制剂的制备方法
CN118477040B (zh) * 2024-04-11 2025-02-25 河北威远药业有限公司 一种氟雷拉纳溶液的制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962488A (en) * 1998-04-08 1999-10-05 Roberts Laboratories, Inc. Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
DK1294644T3 (da) 2000-06-27 2010-11-08 Procter & Gamble Vandbehandlingssammensætninger
US20050005868A1 (en) * 2003-07-11 2005-01-13 Shepard Allan T. Animal drinking water production
KR101197482B1 (ko) 2004-03-05 2012-11-09 닛산 가가쿠 고교 가부시키 가이샤 이속사졸린 치환 벤즈아미드 화합물 및 유해생물 방제제
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
JP2007319124A (ja) * 2006-06-02 2007-12-13 Nippon Tablet Kk 健康食品
WO2008122375A2 (en) 2007-04-10 2008-10-16 Bayer Cropscience Ag Insecticidal aryl isoxazoline derivatives
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
CA2971008A1 (en) 2007-06-27 2008-12-31 E. I. Du Pont De Nemours And Company Animal pest control method
US20090024541A1 (en) * 2007-07-20 2009-01-22 Gary Kremen Power purchase methods, agreements and financial instruments for tax-advantaged financing residential renewable energy equipment
TWI556741B (zh) * 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
WO2010003923A1 (en) * 2008-07-09 2010-01-14 Basf Se Pestcidal active mixtures comprising isoxazoline compounds i
US7951404B2 (en) 2008-07-11 2011-05-31 Sanosil Ag Concentrate for preparing a disinfectant and methods for its preparation and use
WO2010079077A1 (en) 2008-12-18 2010-07-15 Novartis Ag Isoxazolines derivatives and their use as pesticide
WO2010070068A2 (en) 2008-12-19 2010-06-24 Novartis Ag Organic compounds
TR201907244T4 (tr) 2009-12-17 2019-06-21 Boehringer Ingelheim Animal Health Usa Inc Anti̇parazi̇ti̇k di̇hi̇droazol bi̇leşi̇mleri̇
US8999889B2 (en) * 2010-02-01 2015-04-07 Basf Se Substituted ketonic isoxazoline compounds and derivatives for combating animal pests
JP2013523805A (ja) 2010-04-08 2013-06-17 ゾエティス・エルエルシー 殺虫剤および殺ダニ剤としての置換3,5−ジフェニル−イソオキサゾリン誘導体
WO2012155352A1 (en) 2011-05-19 2012-11-22 Eli Lilly And Company Dihydroisoxazole compounds, parasiticidal uses and formulations thereof
BR112014004235A2 (pt) 2011-08-25 2017-03-21 Syngenta Participations Ag derivados de isoxazolina como compostos inseticidas
WO2013026695A1 (en) 2011-08-25 2013-02-28 Syngenta Participations Ag Isoxazoline derivatives as insecticidal compounds
TWI567064B (zh) * 2011-09-12 2017-01-21 龍馬躍有限公司 包含異唑啉活性劑之殺寄生蟲組合物、方法及其用途
WO2015048371A1 (en) 2013-09-30 2015-04-02 Zoetis Llc Long-acting spiro-isoxazoline formulations
US9371293B2 (en) 2013-10-25 2016-06-21 Sumitomo Chemical Company, Limited Isoxazoline compound composition
ES2905848T3 (es) 2013-11-01 2022-04-12 Boehringer Ingelheim Animal Health Usa Inc Compuestos de isoxazolina antiparasitarios y plaguicidas
AU2014363695B2 (en) * 2013-12-10 2018-12-13 Intervet International B.V Antiparasitic use of isoxazoline compounds
MX373872B (es) * 2013-12-20 2020-03-26 Intervet Int Bv Composiciones de isoxazolina y uso de las mismas en la prevención o tratamiento de infestaciones parasitarias en animales.
CN105979944A (zh) * 2013-12-20 2016-09-28 英特维特国际股份有限公司 异噁唑啉衍生物用于治疗或预防家禽中的节肢动物侵袭的用途
AU2015343387A1 (en) * 2014-11-03 2017-05-18 Zoetis Services Llc Palatable chewable veterinary composition

Also Published As

Publication number Publication date
EP3313400B1 (en) 2022-06-15
BR112017027855A2 (enExample) 2018-08-21
CN107750159B (zh) 2021-10-29
HUE059228T2 (hu) 2022-10-28
US20180169073A1 (en) 2018-06-21
BR112017027855B1 (pt) 2022-11-16
US20190343808A1 (en) 2019-11-14
JP2018521995A (ja) 2018-08-09
PL3313400T3 (pl) 2022-07-25
EP3313400A1 (en) 2018-05-02
MX2017016671A (es) 2018-03-15
US11878006B2 (en) 2024-01-23
CN107750159A (zh) 2018-03-02
US20210354283A1 (en) 2021-11-18
ES2920394T3 (es) 2022-08-03
US11179372B2 (en) 2021-11-23
MX383746B (es) 2025-03-14
WO2016207234A1 (en) 2016-12-29

Similar Documents

Publication Publication Date Title
JP6933983B2 (ja) 衛生化飲料水と共に使用するためのビタミンeを含有するイソオキサゾリン溶液
RU2688919C1 (ru) Изоксазолиновые композиции и их применение в провилактике или лечении паразитарных инвазий животных
US12128032B2 (en) Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry
RU2796536C9 (ru) Применение изоксазолиновых соединений на домашней птице
RU2796536C2 (ru) Применение изоксазолиновых соединений на домашней птице
RU2791637C2 (ru) Изоксазолиновые композиции и их применение в профилактике или лечении паразитарных инвазий животных
MXPA97007900A (en) Sanitation composition especially adapted for the treatment of buildings for animal crises

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190621

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190621

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200707

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200924

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210312

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210817

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210820

R150 Certificate of patent or registration of utility model

Ref document number: 6933983

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250